Lepu Medical Technology (Beijing) Co., Ltd.

SZSE:300003 Stock Report

Market Cap: CN¥20.5b

Lepu Medical Technology (Beijing) Future Growth

Future criteria checks 4/6

Lepu Medical Technology (Beijing) is forecast to grow earnings and revenue by 29.9% and 17.9% per annum respectively. EPS is expected to grow by 29.7% per annum. Return on equity is forecast to be 11.9% in 3 years.

Key information

29.9%

Earnings growth rate

29.7%

EPS growth rate

Medical Equipment earnings growth22.9%
Revenue growth rate17.9%
Future return on equity11.9%
Analyst coverage

Good

Last updated20 Aug 2024

Recent future growth updates

Recent updates

Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Aug 16
Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Jun 23
Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

May 31
Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

May 13
Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Feb 28
Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Earnings and Revenue Growth Forecasts

SZSE:300003 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202611,5582,664N/A3,2477
12/31/202510,1532,300N/A2,7168
12/31/20248,8931,991N/A2,7678
6/30/20247,0629943031,008N/A
3/31/20247,4651,1434881,266N/A
12/31/20237,9801,258146990N/A
9/30/20239,1071,7466421,573N/A
6/30/20239,5771,8967941,754N/A
3/31/202310,4982,2541,3202,208N/A
12/31/202210,6092,2041,8852,791N/A
9/30/20229,7871,6081,6112,558N/A
6/30/20229,4731,2621,1182,106N/A
3/31/202210,4601,5391,2112,212N/A
1/1/202210,6601,7192,0783,062N/A
9/30/202110,2861,7501,9542,812N/A
6/30/202110,3212,3872,2693,086N/A
3/31/20219,1212,1442,5673,284N/A
12/31/20208,0391,8021,4902,090N/A
9/30/20208,3032,0861,7002,312N/A
6/30/20208,1121,7101,8992,424N/A
3/31/20207,5841,5261,2941,839N/A
12/31/20197,7961,7251,4271,990N/A
9/30/20197,6521,6871,1521,834N/A
6/30/20197,3231,5649981,669N/A
3/31/20196,7991,4988771,557N/A
12/31/20186,3561,2194291,501N/A
9/30/20185,8321,3043611,241N/A
6/30/20185,3101,2142061,063N/A
3/31/20184,942970N/A954N/A
12/31/20174,538899N/A913N/A
9/30/20174,234874N/A772N/A
6/30/20173,974797N/A728N/A
3/31/20173,701734N/A770N/A
12/31/20163,468679N/A692N/A
9/30/20163,318649N/A778N/A
6/30/20163,113610N/A693N/A
3/31/20162,938569N/A509N/A
12/31/20152,769521N/A436N/A
9/30/20152,419520N/A374N/A
6/30/20152,208500N/A363N/A
3/31/20151,934458N/A324N/A
12/31/20141,669423N/A348N/A
9/30/20141,578405N/A277N/A
6/30/20141,490385N/A284N/A
3/31/20141,375362N/A330N/A
12/31/20131,303362N/A330N/A
9/30/20131,215353N/A295N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300003's forecast earnings growth (29.9% per year) is above the savings rate (2.9%).

Earnings vs Market: 300003's earnings (29.9% per year) are forecast to grow faster than the CN market (21.9% per year).

High Growth Earnings: 300003's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300003's revenue (17.9% per year) is forecast to grow faster than the CN market (13.4% per year).

High Growth Revenue: 300003's revenue (17.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300003's Return on Equity is forecast to be low in 3 years time (11.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y